Heart rhythm · 2026
Hemolysis and renal tubular injury after pulsed field ablation: A comparison between two commercially available platforms.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miyajima Keisuke, Ishihara Kazuku, Yamada Takeru, Yabuzaki Ryosuke, Oda Yusuke, Nanjo Kota, Nakamura Kazuya, Okazaki Ayako, Kawaguchi Yoshitaka, Wakabayashi Yasushi, Maekawa Yuichiro
Аннотация
BACKGROUND: Pulsed field ablation (PFA) causes intravascular hemolysis, and the degree of hemolysis differs between available platforms. Whether platform-dependent differences in hemolysis translate into differences in renal tubular injury has not been evaluated.
OBJECTIVE: To compare hemolysis markers, urinary tubular injury biomarkers, and short-term renal function between 2 commercially available PFA platforms in consecutive patients undergoing AF ablation.
METHODS: We retrospectively analyzed 131 consecutive patients treated with a circular multielectrode array platform (PulseSelect; n = 72) or a pentaspline platform (Farapulse; n = 59). Serum haptoglobin, hemoglobin, lactate dehydrogenase, total bilirubin, and creatinine, and urinary N-acetyl-β-D-glucosaminidase (NAG), β2-microglobulin, and α1-microglobulin were measured the day before and the day after ablation. Periprocedural changes were compared between platforms.
RESULTS: Serum haptoglobin decreased significantly after the procedure in both groups, with a greater decrease in the Farapulse group (ΔHaptoglobin: -59 [-71 to -33] vs -36 [-51 to -24] mg/dL; P < .001). Serum lactate dehydrogenase and total bilirubin also increased more with Farapulse (P = .002 and P = .001). Despite the greater hemolytic response, changes in urinary N-acetyl-β-D-glucosaminidase, β2-microglobulin, and α1-microglobulin did not differ significantly (all P > .05), nor did serum creatinine (P = .948). Device type was an independent predictor of ΔHaptoglobin and Δtotal bilirubin on multivariable regression but was not associated with any renal tubular biomarker. In patients with eGFR-defined chronic kidney disease, platform-dependent hemolysis persisted, but urinary tubular biomarker changes remained comparable.
CONCLUSION: Farapulse was associated with greater intravascular hemolysis than PulseSelect across multiple markers, but these differences did not translate into detectable renal tubular injury under the procedural conditions of this study.
OBJECTIVE: To compare hemolysis markers, urinary tubular injury biomarkers, and short-term renal function between 2 commercially available PFA platforms in consecutive patients undergoing AF ablation.
METHODS: We retrospectively analyzed 131 consecutive patients treated with a circular multielectrode array platform (PulseSelect; n = 72) or a pentaspline platform (Farapulse; n = 59). Serum haptoglobin, hemoglobin, lactate dehydrogenase, total bilirubin, and creatinine, and urinary N-acetyl-β-D-glucosaminidase (NAG), β2-microglobulin, and α1-microglobulin were measured the day before and the day after ablation. Periprocedural changes were compared between platforms.
RESULTS: Serum haptoglobin decreased significantly after the procedure in both groups, with a greater decrease in the Farapulse group (ΔHaptoglobin: -59 [-71 to -33] vs -36 [-51 to -24] mg/dL; P < .001). Serum lactate dehydrogenase and total bilirubin also increased more with Farapulse (P = .002 and P = .001). Despite the greater hemolytic response, changes in urinary N-acetyl-β-D-glucosaminidase, β2-microglobulin, and α1-microglobulin did not differ significantly (all P > .05), nor did serum creatinine (P = .948). Device type was an independent predictor of ΔHaptoglobin and Δtotal bilirubin on multivariable regression but was not associated with any renal tubular biomarker. In patients with eGFR-defined chronic kidney disease, platform-dependent hemolysis persisted, but urinary tubular biomarker changes remained comparable.
CONCLUSION: Farapulse was associated with greater intravascular hemolysis than PulseSelect across multiple markers, but these differences did not translate into detectable renal tubular injury under the procedural conditions of this study.